Acne
Does Accutane Work for Hormonal Acne?
“Hormonal acne” is what most people call the breakouts that focus around the jawline, flare with their cycle, or refuse to respond to what worked in the past. A common question that follows is whether Accutane (isotretinoin), a drug that doesn’t target hormones, can fix acne that hormones are driving.
Does Accutane Work for Hormonal Acne?
Yes. Accutane (isotretinoin) works on hormonal acne because it targets the oil gland directly, reducing the number of oil-producing cells and the amount of oil they make, rather than whatever is stimulating the gland in the first place.
Hormones drive acne by pushing glands to make more oil. Isotretinoin shrinks the glands’ fundamental capacity to respond, no matter what the signal is.
This is why the American Academy of Dermatology strongly recommends oral isotretinoin for acne that is severe, causing scarring or psychosocial burden, or failing standard oral or topical treatment. The recommendation applies regardless of what pattern the acne takes.
Reynolds et al. (2024). Journal of the American Academy of Dermatology
What “Hormonal Acne” Actually Means
Hormonal acne is not a formal diagnosis, but the pattern people mean by it is well known. In adult women, inflammatory lesions tend to concentrate around the lower chin, jawline and neck, the comedones are more often closed, and the acne is usually mild to moderate yet stubborn. It can be carried over from the teenage years or appear for the first time in adulthood.
Dréno et al. (2013). Journal of the European Academy of Dermatology and Venereology
Most women with this pattern have normal hormone levels; the skin is just more sensitive to those hormones. A minority have an underlying condition such as polycystic ovary syndrome (PCOS), now renamed polyendocrine metabolic ovarian syndrome (PMOS), which we discuss below. Rarely, congenital adrenal hyperplasia is the cause. A dermatologist may order androgen testing if the signs point that way.
The Honest Asterisk: Relapse
Now that we know isotretinoin clears hormonal acne, we need to look at the overall picture and how these systems in the body connect.
Isotretinoin clears hormonal acne, but it doesn’t change the underlying hormonal drivers, which are still there when the course ends. That shows up in the relapse data. In a 2025 analysis of nearly 20,000 patients, women had a 43% higher relapse rate than men. An earlier review of 1,453 patients found more of the same: patients needing a second course were more likely to be women (61% versus 47%).
Lai & Barbieri (2025). JAMA Dermatology
Rademaker (2016). International Journal of Dermatology
In practice, this means some women with hormonal-pattern acne clear and stay in remission. Others clear and then need a maintenance strategy afterwards, which is where a hormone-specific medication like spironolactone can fit. Neither outcome means isotretinoin “didn’t work.”
The things that lower relapse odds for everyone, an adequate cumulative dose and continuing treatment past the point the skin clears, apply here too.
What About PCOS (PMOS)?
A minority of women with hormonal acne have an underlying condition long known as polycystic ovary syndrome (PCOS). In May 2026 it was renamed polyendocrine metabolic ovarian syndrome (PMOS) by a global effort of 56 patient and professional organisations, because the old name reduced a whole-body hormonal condition to a misunderstanding about ovarian cysts. You’ll see both names for a few years, so we use both here.
Endocrine Society (2026). Global effort changes the name of a significant women’s health condition
PMOS is a disorder involving multiple systems in the body, including hormonal balance and metabolic function, along with the downstream effects: weight, skin, cycle and mental health.
You can think of PMOS as a car with a hypersensitive alarm system. In a standard car, the alarm only goes off if someone smashes a window. In a car with PMOS wiring, the alarm is set so tightly that a heavy gust of wind or a loud truck driving by triggers the siren. The “siren” in PMOS is the ovaries flooding the body with testosterone. The car isn’t broken; its default settings are just hyper-reactive.
Isotretinoin still works on the acne. In a prospective study of 40 women with PCOS and acne, a standard course cut the mean acne score from 11.6 to 1.7, and ovarian volume fell as well, although the authors were careful to call for larger controlled trials before drawing conclusions about the ovarian effect.
Elnagar et al. (2024). Journal of Ovarian Research
For the acne itself, the guidelines don’t change: severity and scarring decide whether isotretinoin is appropriate, not the diagnosis behind the acne. What PMOS changes is the rest of the plan. Because the androgen excess persists after the course, a provider may want a hormonal workup and may pair or follow isotretinoin with treatment for the condition itself.
Treating PMOS: The Whole Picture
We know how frustrating it is to be facing an issue with acne or hormones and be handed one treatment for one part of the problem while the overall picture is ignored. It’s why our physicians ask about your cycle, weight and history, not just your skin, and why acne treatment for PMOS is often one piece of a bigger plan.
That bigger plan can work. In a 2026 study that followed 468 women with PCOS through treatment with insulin-sensitising and weight-loss medications such as metformin and GLP-1s, about 1 in 8 reached full clinical remission: regular periods, testosterone back to normal, and ovaries that looked normal again on 3D ultrasound. It took about a year on average, and a lower BMI was one of the strongest predictors.
Su et al. (2026). Frontiers in Endocrinology
Even in remission, though, the underlying wiring stays hyper-reactive. PMOS is a feedback loop: if you’re genetically sensitive to an insulin spike, your ovaries can read that insulin as a signal to churn out testosterone, and the whole cycle starts again. The gains are only as durable as the habits and treatment behind them, which is why a personalised plan, tracked over the long term, matters more here than in almost any other kind of acne.
The 2023 international PCOS guideline lays out the medical options by goal:
- Cycle regulation and excess hair: combined oral contraceptive pills are the first-line option; they regulate periods, protect the uterine lining and lower testosterone. Progestin-only options exist for women who can’t take oestrogen.
- Insulin resistance and weight: metformin is the standard choice, and GLP-1 medications can be considered when weight is the main driver.
- Acne and excess hair (hirsutism): anti-androgens such as spironolactone block testosterone at the tissue level, usually alongside the pill or with reliable contraception.
- Trying to conceive: ovulation-inducing medications such as letrozole are used to stimulate egg release.
Teede et al. (2023). The Journal of Clinical Endocrinology & Metabolism
Lifestyle is the foundation under all of it. The core is improving how you fuel and move your body, which targets the metabolic issues that drive PMOS: steadier blood sugar, strategic exercise and weight management can be immensely helpful.
Supplements deserve an honest word. Inositol, usually a combination of myo-inositol and D-chiro-inositol, is the best studied. The review commissioned for the 2023 guideline found possible benefit for some metabolic measures and ovulation, but called the overall evidence limited and inconclusive. It’s low-risk and widely used, but it is not a substitute for the treatments above. Other supplements people add, such as vitamin D, magnesium and omega-3s, have thinner evidence and are worth raising with your provider rather than self-prescribing.
Fitz et al. (2024). The Journal of Clinical Endocrinology & Metabolism
Accutane vs. Spironolactone
Accutane (isotretinoin) and spironolactone are often compared, but in reality they aren’t rivals at all. Isotretinoin works by shrinking the oil gland and is the only medical acne treatment capable of inducing remission. Spironolactone is an anti-androgen: it blocks the hormone signal at the gland, works only while you take it, and in acne is used in women.
| Isotretinoin (Accutane) | Spironolactone | |
|---|---|---|
| How it works | Shrinks oil glands, reduces sebum | Blocks androgen signalling to the gland |
| Course | Finite course, typically 4 to 6 months | Ongoing, taken continuously |
| Typical timeline | One course of 15 to 20 weeks | Months: clearer benefit at 24 weeks than at 12 |
| Guideline position | Strongly recommended for severe, scarring or treatment-resistant acne | Conditionally recommended for women |
| Best fit | Severe or scarring acne of any pattern | Mild to moderate persistent hormonal acne in women, or maintenance |
Spironolactone has solid evidence for the job it does. In a 410-woman randomised trial, 82% of women on spironolactone reported their acne had improved at 24 weeks versus 63% on placebo, and treatment success as judged by the investigators was 19% versus 6% at 12 weeks. A 2025 meta-analysis of five placebo-controlled trials found that improvement in acne severity, as rated by clinicians, was over six times more likely with spironolactone, with no significant increase in menstrual irregularity or breast tenderness.
Ghanem et al. (2025). Journal of Cosmetic Dermatology
Side effects are the biggest difference between the two. In the largest spironolactone trial, headaches were the main thing that separated it from placebo (20% versus 12%), and there were no serious adverse reactions. Isotretinoin’s side effects are more noticeable but time-limited: dryness for almost everyone, plus the monitoring and pregnancy rules covered in our isotretinoin guide.
Neither drug is used in pregnancy, for different reasons. Isotretinoin causes severe birth defects, which is what the iPLEDGE program exists to prevent. Spironolactone’s label says to avoid it in pregnancy because of the potential risk to a male fetus.
US Food and Drug Administration (2018). Aldactone label
Spironolactone isn’t the only hormonal option. Combined oral contraceptives carry the same conditional recommendation in the dermatology guidelines, and for some women the pill does double duty.
For men, the picture is simpler. The spironolactone trials enrolled only women, and as an anti-androgen it is not used for acne in men. A man with stubborn jawline acne is choosing between standard retinoids, either oral (isotretinoin) or topical (tretinoin), and the other standard options, not between isotretinoin and a hormonal treatment.
Who Decides
As you can see, treating hormonal acne isn’t always simple. Pattern, history and labs together point to the right tool, and your physician has to weigh all three to find the medications and lifestyle changes that will get you to your goals and keep you there.
Severe, persistent or scarring acne tilts the decision toward isotretinoin regardless of the pattern, because it is the one treatment that targets remission. For acne on the milder side, spironolactone alone, with or without a supporting topical such as tretinoin, can be the answer.
They can also be used in sequence, or together. Isotretinoin can put acne into remission, then spironolactone holds the line against the hormonal pattern creeping back. No trial has tested the combination and the Accutane label lists no interaction with spironolactone, so taking both at once is a decision for your prescriber, based on your case.
If you’ve already tried the standard options, that history is one of the most useful things you can bring to your visit, because failing standard therapy is one of the guideline criteria for isotretinoin.
How to Get Prescribed Isotretinoin (Accutane) Online
If you’re wondering how or where to get isotretinoin, Happyglow connects you with US-licensed physicians who decide whether starting isotretinoin is right for you, entirely online.
- Start your visit. Answer a few questions about your health and goals (~5 min).
- A physician reviews. They determine whether isotretinoin is appropriate for you or recommend a better fit, such as spironolactone.
- Delivered to your door. If approved, your prescription ships free, with refills coordinated with your monthly check-ins.
See if isotretinoin is right for you
Not approved? You’re refunded in full.
Common questions
Does Accutane Work for Hormonal Acne?
Yes. Isotretinoin targets the oil gland directly, shrinking it and cutting oil production whatever is stimulating it, so it clears hormonally driven acne as well as any other kind. It is the only acne treatment capable of producing lasting remission. The caveat is that the hormonal driver is still there after the course, so some women need a maintenance plan afterwards.
Will Hormonal Acne Come Back After Accutane?
It can. In a 2025 analysis of nearly 20,000 patients, women had a 43% higher relapse rate than men, although they were less likely to need a second course, which suggests their relapses were often milder or handled with other treatments. Reaching an adequate cumulative dose and treating past the point of clearance both lower the odds, and a provider can plan maintenance if acne returns.
Spironolactone vs. Accutane: Which Is Better for Hormonal Acne?
They do different jobs. Isotretinoin acts on the oil gland itself and is the only treatment that can put acne into remission, which is why it is the pick for severe, scarring or stubborn acne of any pattern. Spironolactone is an anti-androgen for women that works while you take it and suits milder, persistent hormonal acne. They are sometimes used in sequence, or together, and a physician decides which fits your severity and history.
Does Accutane Work for PCOS Acne?
Yes. Isotretinoin targets the oil glands directly, so it works whatever is driving the acne. In a small 2024 study of 40 women with PCOS, a standard course cut acne scores substantially. PCOS, renamed polyendocrine metabolic ovarian syndrome (PMOS) in 2026, is a metabolic and hormonal condition, so a provider may pair the acne treatment with medication, lifestyle changes or a hormonal workup for the condition itself.
Does Accutane Affect Your Hormones?
Only slightly, and not in a way it is prescribed for. In a small study of 36 women on low-dose isotretinoin for three months, testosterone and DHT fell, but the study had no control group and did not measure whether that changed relapse. Isotretinoin is not a hormonal medicine; it works on the oil gland, which is why its results do not depend on your hormone levels.
Sources
Primary evidence
- Individual studyLai & Barbieri (2025). Acne Relapse and Isotretinoin Retrial in Patients With Acne · JAMA Dermatology (Q1)
- Individual studySanter et al. (2023). Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial · BMJ (Q1)
- Meta-analysisGhanem et al. (2025). Efficacy and Safety of Oral Spironolactone for Women With Acne Vulgaris: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials With Trial Sequential Analysis · Journal of Cosmetic Dermatology (Q1)
- Meta-analysisFitz et al. (2024). Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines · The Journal of Clinical Endocrinology & Metabolism
- Individual studyRademaker (2016). Making sense of the effects of the cumulative dose of isotretinoin in acne vulgaris · International Journal of Dermatology (Q1)
- Individual studySu et al. (2026). Remission of polycystic ovary syndrome based on the recovery of ovarian morphology identified by three-dimensional ultrasonography: a retrospective study · Frontiers in Endocrinology (Q1)
- Individual studyFeily et al. (2020). The effect of low-dose isotretinoin therapy on serum androgen levels in women with acne vulgaris · International Journal of Women's Dermatology (Q2)
- Individual studyElnagar et al. (2024). The impact of oral isotretinoin on ovarian functions of acne patients complaining of polycystic ovarian syndrome: a prospective study · Journal of Ovarian Research
Official sources
- Press release(2026). Global effort changes the name of a significant women's health condition · Endocrine Society
- FDA labelAccutane (isotretinoin) Capsules Label · FDA
- FDA label(2018). Aldactone (spironolactone) Tablets Label · FDA
Expert context
- Clinical guidelineReynolds et al. (2024). Guidelines of care for the management of acne vulgaris · Journal of the American Academy of Dermatology (Q1)
- Clinical guidelineTeede et al. (2023). Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome · The Journal of Clinical Endocrinology & Metabolism
- Narrative reviewDréno et al. (2013). Adult female acne: a new paradigm · Journal of the European Academy of Dermatology and Venereology (Q1)
- Narrative reviewPaichitrojjana et al. (2023). Oral Isotretinoin and Its Uses in Dermatology: A Review · Drug Design, Development and Therapy (Q1)
- Narrative reviewDias da Rocha et al. (2024). Unveiling the Nuances of Adult Female Acne: A Comprehensive Exploration of Epidemiology, Treatment Modalities, Dermocosmetics, and the Menopausal Influence · International Journal of Women's Health
Background
- EncyclopediaIsotretinoin · Wikipedia